Acorda Therapeutics reports positive CVT-301 Results
February 09, 2017 at 12:28 PM EST
Acorda Therapeutics announced the results from a late-stage clinical trial of the drug candidate, CVT-301.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.